Moderna Says its Vaccine for Ages Under 6 Will be Ready for U.S. Review in June
Moderna Inc's (MRNA.O) chief medical officer said on Sunday the company's vaccine for children under 6 years old will be ready for review by a Food and Drug Administration panel when it meets in June. Awesome!
Photo Credit: Mufid Majnun